Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Kåre Schultz new CEO of Teva - Nordic Life Science – the leading Nordic life science news service
Teva CEO Schultz likely won't renew employment contract: reports
After turbulent years, Teva CEO Schultz forecasts stability - Israel News - The Jerusalem Post
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
Teva Rockets After Hiring Former Novo Nordisk Exec As CEO | Investor's Business Daily
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
teva News and latest stories | The Jerusalem Post
Teva Pharmaceuticals (@TevaUSA) / Twitter
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Three-Stock Lunch: AMD, HAS & TEVA
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals - News, Articles etc. - European Pharmaceutical Review
Teva proposes settlement in US opioid lawsuits | Israel National News - Arutz Sheva
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges - WSJ
Teva reaches $523 million deal to settle opioid lawsuit with New York | CNN Business
Teva CEO Kåre Schultz discusses company's latest quarter and opioid settlement - YouTube
Teva Settles Arkansas Price-Fixing Case for $931K | Arkansas Business News | ArkansasBusiness.com
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
Teva banks on blockbuster Austedo sales as COVID-19, Copaxone generics take their toll | Fierce Pharma
In The News: Teva, Superfeet, Red Wing - Footwear Insight
Teva, Allergan settle roles in opioid crisis for $4.25B, $2.37B respectively - Top Class Actions
